Monday, November 14, 2016

BRIEF-Cytori granted FDA orphan drug designation for ECCS-50 in scleroderma

* Cytori granted FDA orphan drug designation for ECCS-50 in

scleroderma

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)